FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Lupin Pharmaceuticals Testosterone Topical Solution Recall

Testosterone Topical Solution, 30mg/1

Lupin Pharmaceuticals Inc. · Baltimore, MD

Risk level
Class III
Reported by FDA
Mar 27, 2019
Recall ID
D-1010-2019
Check your lot numberHow we source this data

Summary

Lupin Pharmaceuticals recalled Testosterone Topical Solution starting Mar 13, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1010-2019 on Mar 27, 2019. Reason: Defective Container: Repetitive complaints received indicating pump not working. Status: Terminated.

Why it was recalled

Defective Container: Repetitive complaints received indicating pump not working.

Product description

Testosterone Topical Solution, 30mg/1.5mL, 110mL bottles, Rx only, Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775 INDIA, NDC 68180-943-11

Lot numbers, UPCs & expiration codes

Lot # K700086, Exp 11/2019

Where it was sold

Recalled product was distributed to 7 major wholesale/drug chain distributors and 1 supermarket chain that may have further distribute the product throughout the United States.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1010-2019
Classification
Class III
Status
Terminated
Recall initiated
Mar 13, 2019
FDA report date
Mar 27, 2019
Quantity
3,200 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Lupin Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-1010-2019, exactly as published.

Show all FDA fields
City
Baltimore
State
MD
Status
Terminated
Country
United States
Event ID
82392
Address
111 S Calvert St Fl 21ST
Code information
Lot # K700086, Exp 11/2019
Postal code
21202-6174
Report date
Mar 27, 2019
Product type
Drugs
Recall number
D-1010-2019
Classification
Class III
Recalling firm
Lupin Pharmaceuticals Inc.
Product quantity
3,200 bottles
Termination date
Jun 26, 2020
Reason for recall
Defective Container: Repetitive complaints received indicating pump not working.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Testosterone Topical Solution, 30mg/1.5mL, 110mL bottles, Rx only, Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775 INDIA, NDC 68180-943-11
Distribution pattern
Recalled product was distributed to 7 major wholesale/drug chain distributors and 1 supermarket chain that may have further distribute the product throughout the United States.
Recall initiation date
Mar 13, 2019
Initial firm notification
Letter
Center classification date
Mar 19, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1010-2019, published Mar 27, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls